Oncology Books

Book SynopsisRecent global cancer statistical data has clearly indicated that prostate cancer is currently the second most frequently diagnosed cancer (at 15% of all male cancers) and globally the sixth leading cause of cancer death in males. This book is a summary of prostate cancer, covering its incidence, epidemiology, and current treatment options. It also serves as an up-to-date review of the status of currently available alternative and complementary medicines for treating prostate cancer, including various plant extracts, herbal formulations, natural products, yoga, acupuncture, Ayurveda, homeopathy, and Siddha medicines used in prostate cancer therapy.Trade Review"Exceptionally well organized and presented, "Complementary and Alternative Medicines in Prostate Cancer" is unreservedly recommended as a core addition to college and university library Health/Medicine collections in general, and Prostate Cancer supplemental studies reading lists in particular."-- James A. Cox, Editor-in-Chief, Midwest Book ReviewTable of ContentsProstate cancer: an introduction. Prostate cancer epidemiology. Molecular biology of prostate cancer. Current treatments and reasons for treatment failure. Preclinical status of novel approaches for prostate cancer therapy. Triterpenoids and sesquiterpenes. Curcumin. Resveratrol.Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside. Phyllanthus sp: Bitter melon extract. Kava. Plumbagin. Urokinase inhibitors from plants. Chinese Herbal among Prostate Cancer Patients: A Population-Based Study in Taiwan. lternol.Betel leaf.Spice derived anticancer molecules for prostate cancer. Nutraceuticals and prostate cancer. Isoflavinoids. Pomegranate. Green tea. Broccoli. Pomi-T supplements. Other forms of CAM. Yoga and prostate cancer. Acupuncture. Homeopathy. Siddha medicines.

Read more less

Book SynopsisObject Lessons is a series of short, beautifully designed books about the hidden lives of ordinary things. One in two men and one in three women will develop invasive cancer. Tumors have the power to redefine identities and change how people live with one another.Tumor takes readers on an intellectual adventure around the attitudes that shape how humans do scientific research, treat cancer, and talk about disease, treatment, and death. With poetic verve and acuity, Anna Leahy explores why and how tumors happen, how we think and talk about them, and how we try to rid ourselves of them. Object Lessons is published in partnership with an essay series in The Atlantic.Trade ReviewLeahy looks a tough subject right in the eyes, and tells its story with grace, insight, alacrity, and wit. * David Eagleman, Stanford neuroscientist, New York Times bestselling author of Incognito: The Secret Lives of the Brain, and host of the PBS series The Brain with David Eagleman *In clear, compelling language, Anna Leahy writes with insight and empathy about cancer and the social and cultural dimensions of one of our greatest fears. A blend of science, journalism, and deeply personal storytelling, this book takes a lyrical approach to a complex subject we all face in some way. * Kristen Iversen, Professor of English & Comparative Literature, University of Cincinnati, USA, and author of Full Body Burden: Growing Up in the Nuclear Shadow of Rocky Flats (2012) *Table of Contents1. Tumor in the Family 2. Terms & Conditions 3. Self/Other(s) 4. Part & Parcel 5. Inside/Outside Notes Index

Read more less

Book SynopsisIn IN MY HANDS, surgical oncologist Dr. Steven Curley shares the empowering lessons he's learned over 25 years from his cancer patients' unique stories of struggle, perseverance, and triumph.As Chief of Surgical Oncology at Baylor College of Medicine, Dr. Steven Curley has worked with cancer patients for over two decades. While his life's work has been to help his patients live longer lives, he found that they helped him in ways he never could have expected.IN MY HANDS is a rare, often emotional look at some of Dr. Curley's real patients and real situations in modern cancer care. These stories of resilience, hope, and determination changed and inspired Dr. Curley, and he uses these same stories to encourage patients dealing with the fear and uncertainty coupled with a diagnosis of cancer.Every story in the book has a theme inspired by his patients: Hope, Courage, Strength, Determination, Wonder, Cooperation, Creativity, Diligence, Service, Perseverance, Wisdom, Grace, Consideration, Gratitude, Discernment, Reverence, Resourcefulness, Faith, Beauty, Acceptance, and Empathy. Some are positive messages, reminding us of the importance of maintaining balance between family, work, and leisure activities. Others are examples of the remarkable resilience of the human spirit when facing the reality of and the surgical risks that accompany a cancer diagnosis. Realistically, despite remarkable advances in multidisciplinary cancer care, some remind us cancer is still a potentially lethal and destructive disease affecting patients and the family and friends supporting them.While many people are told that there is no hope in their situation, Dr. Curley's patients taught him to always provide hope, to push the envelope and give people a chance, and that hope is a critical component of treatment and care. IN MY HANDS is medical narrative at its finest, and provides insight into medicine and patient care along with fascinating details about one of our most feared diseases.

Read more less

Book SynopsisThe Classic Text—Expanded, Updated...More Authoritative than Ever!Cutaneous Melanoma is the definitive and most authoritative textbook on melanoma used worldwide. This 5th edition provides the most up-to-date and comprehensive information needed for the clinical management and scientific study of melanoma. Written by the leading melanoma experts from the United States, Australia, and Europe, this new edition collectively incorporates the clinical outcomes of more than 60,000 patients treated at major melanoma centers throughout the world.Comprehensive Coverage—from Prevention to Advanced TreatmentThis new edition provides in-depth coverage, ranging from precursors of melanoma to advanced stages of metastatic disease; from melanoma genes to population-based epidemiology; and from prevention of melanoma to all forms of multidisciplinary treatments. Basic principles of diagnosis and pathologic examination are combined with treatment approaches for the many clinical presentations. Clinical management is supported by statistical data about natural history, prognosis, and treatment results. The latest information on staging and prognosis, as well as randomized prospective clinical trials involving surgical treatment and systemic treatments, is included. This volume presents a balanced perspective of the risks and benefits involved in each treatment modality. The book also contains: 1) a comprehensive color atlas of melanoma and its precursors, 2) illustrated surgical and perfusion techniques for every stage and anatomic location of melanoma, and 3) complex genetic and molecular pathways involving melanoma biology. Every drug and biologic agent in use today is described with indications and efficacy.Entirely Revised and UpdatedSeven new chapters discuss the emerging clinical data on the use of biomarkers, adjuvant therapies, targeted therapies, and immune modulation as well as significant clinical research advances in the clinical management of melanoma. The remaining 37 chapters have been extensively updated and revised to include the latest clinical, radiological, and pathological data and clinical trial advances.Cutaneous Melanoma, 5th Edition, retains the logical organization and clarity of expression responsible for its enduring popularity over the last 23 years. This volume will become an invaluable part of your library and a trusted resource that you will refer to again and again.The most comprehensive reference on melanoma available today! New Chapters Include: Clinical Genetics and Risk Assessment Sentinel Lymph Node and Regional Micrometastases Multidisciplinary Management of CNS Metastases Adjuvant Therapy for Cutaneous Melanoma Immune Modulation Therapy Using Anti-CTLA-4 Monoclonal Antibodies Melanoma-Specific Targeted Therapies Biomarkers for Cutaneous Melanoma Trade Review"This is the fourth edition of the book that is no doubt the premier text on cutaneous melanoma. The book is oriented to all health care workers and researchers involved in the care of patients with melanomas. This includes, but is not limited to, the dermatologist, medical oncologist, surgical oncologist, radiation oncologist, and cosmetic surgeons, as well as nurses and other practitioners who diagnose or treat patients with melanoma. The 73 distinguished contributors have combined to put together 39 chapters in 7 parts or sections. ...The photos are outstanding and the information invaluable. The book belongs in every physician’s library, whatever his or her specialty, to raise awareness of the deadly disease."—The American Journal of Cosmetic Surgery"Overall, the text is easy to use and well indexed. I find that it is my reference text of choice for any melanoma-related questions that arise during the day. The authors should be commended for their fine and highly accessible work."—American Society for Dermatologic Surgery"…should serve as an invaluable source of information to all clinicians involved in the care of patients with malignant melanoma and to basic scientists who want to become more familiar with various clinical aspects of the disease. I intend to keep it on my desk and refer to it in my practice." —Journal of the American Medical AssociationTable of ContentsIntroductionA History of Melanoma: From Hunter to Milton; Arthur J. Sober, Helen M. Shaw, John F. ThompsonJohn Hunter (1728-1793)René Laennec (1781-1826)William Norris (1792-1877)Oliver Pemberton (1825-1897)James Paget (1814-1899)Sir Jonathan Hutchinson (1828-1913)William Sampson Handley (1872-1962)Alexander Breslow (1928-1980)Vincent J. McGovern (1915-1983)Sophie Spitz (1910-1956)Arthur Allen (1910-1994)Wallace H. Clark, Jr. (1924-1997)Thomas B. Fitzpatrick, Jr. (1919-2003)Gerald W. Milton (1924-2007)Epidemiology, Prognosis, and StagingEpidemiology of Melanoma; Bruce K. Armstrong, Alisa M. GoldsteinWorldwide incidence and mortality patternsCorrelates of melanoma riskDemographic correlatesConstitutional correlatesEnvironmental and behavioral correlatesPresent and future trends in melanoma incidence and mortalityPrognostic Factors and Natural History of Melanoma; Jeffrey E. Gershenwald, Charles M. Balch, Seng-jaw Soong, John F. ThompsonAJCC melanoma staging system analyses—overview of the AJCC international melanoma database and 2002 melanoma staging systemBackgroundOverview of the 2002 (sixth edition) AJCC melanoma database and melanoma staging systemValidation of the AJCC melanoma staging systemPrognostic factors in primary melanoma (stages I and II)Prognostic factors in regionally metastatic melanoma: lymph node metastases, satellite lesions, and in-transit metastasesAJCC melanoma database: multivariate analysis for stage III patientsPrognostic factor analyses in patients with distant metastatic melanoma (stage IV)AJCC melanoma database analysis: stage IVMelanoma Staging and Classification; Charles M. Balch, Jeffrey E. Gershenwald, Seng-jaw Soong, Arthur J. Sober, John M. KirkwoodAnatomyPrimary sitesRegional lymph nodesMetastatic sitesRules for classificationClinical stagingPathologic stagingClinical versus pathologic stagingTNM classificationPrimary tumor (T)Regional lymph nodes (N)Distant metastatic melanoma (M)Staging recommendations for metastases from unknown primary siteStage groupingsData-recording criteriaModels for Predicting Melanoma Outcome; Seng-jaw Soong, Shouluan Ding, Daniel G. Coit, Charles M. BalchDescription of the statistical modelHazard functionSurvival functionPredicting outcome from initial diagnosis for patients with localized melanomaHazard function estimation and parametric modeling for localized melanomaPredicting outcome from initial diagnosis for patients with regional melanomaPredicting outcome after a disease-free interval in patients with localized melanomaClinical applicationsClinical scoring systemDisease management decisionsPatient risk classificationPlanning clinical trialsAnalysis of clinical studiesOther applicationsScreening: Clinical Assessment and PathologyMelanoma Prevention and Screening; J. Mark Elwood, Jennifer Kay Makin, Craig A. Sinclair, Robert BurtonPrevention of melanomaReducing personal exposure: shade, clothing, and sunscreensIntervention trials of the prevention of skin cancers and related lesionsBehavioral change programs for reducing personal exposureVitamin DControlling exposure to sunbedsPrevention of melanoma: recommendationsScreening for melanomaUncertainties and conflicts in melanoma screeningEvidence relating to the effectiveness of screeningPrograms of screeningChallenges in the detection of progressive melanomaClinical Genetics and Risk Assessment of Melanoma; Graham J. Mann, Hensin TsaoClinical risk assessmentBaseline risks attributable to age and sexPrevious melanoma or other skin cancerMultiple melanocytic neviSkin and hair color, skin phototype, and frecklingSun exposure and its surrogatesFamily history of melanomaGenetic risk of melanomaMutations in CDKN2A and CDK4 in familial melanomaPancreatic cancer and other phenotypesCDKN2A mutations in sporadic and multiple primary melanomaMelanoma risk to CDKN2A mutation carriersLow-penetrance melanoma susceptibility genesGenetic testing for melanoma risk?Management of high-risk individualsThe futureAcquired Precursor Lesions and Phenotypic Markers of Increased Risk for Cutaneous Melanoma; Scott W. Menzies, Hensin Tsao, Arthur J. SoberPigment phenotypeConstitutive pigmentation (racial)Hair and eye colorOculocutaneous albinismEphelis (freckle)MolesBenign (common) acquired moles (nevi)Atypical molesLentigo malignaClinical Characteristics of Melanoma; Allan C. Halpern, Ashfaq A. Marghoob, Arthur J. SoberPersonal history of skin cancerClinical presentationSigns and symptomsClinical featuresGrowth patternsClinical assessmentHistoryPhysical examinationsDiagnostic accuracy and aids to diagnosisNew technologies for diagnosisImage analysis for diagnosisMultispectral imaging and automated diagnosisConfocal scanning laser microscopyOther techniques: ultrasound imaging, magnetic resonance imaging, and optical coherence tomographyEvolving paradigms in the analysis of dermoscopic imagesHow we analyze imagesBiopsy of Suspected Melanomas; Nanette J. Liégeois,Timothy M. Johnson, Arthur J. SoberPrebiopsy lesion assessmentBiopsy techniquesExcisional biopsyIncisional biopsyFine-needle aspirationFrozen sectionsBiopsy of the nail unitBiopsy of the mucosaPathology of Melanoma; Richard Anthony Scolyer, Martin C. Mihm, Jr., Alistair J. Cochran, Klaus J. Busam, Stanley William McCarthyPathologic assessment of melanocytic tumors: goals and expectationsBiopsy techniques for clinically suspicious melanocytic tumors: the hazards of incomplete biopsiesPathologic examination of the primary melanoma siteClinical correlation for enhancement of pathologic accuracySpecimen orientationMelanoma tumor progression: the concept of radial and vertical growth phasesClinicopathologic classification of melanomaSuperficial spreading melanomaLentigo maligna melanomaAcrolentiginous melanomaNodular melanomaHistologic features of vertical growth phase melanomaPredominantly epithelioid cell vertical growth phasePredominantly spindle cell vertical growth phasePitfallsMixed spindle cell and epithelioid cell vertical growth phaseNevoid vertical growth phase (nevoid melanoma)PrognosticationThe melanoma pathology report including a synoptic formatUncommon melanoma variantsMetastatic melanomaFine-needle biopsy in melanoma patientsClear cell sarcoma (melanoma of soft parts)Molecular pathology of melanomaThe concept of the cancer stem cellThe metastatic niche conceptManagement of Localized MelanomaExcision of Primary Melanoma; Merrick I. RossExcision of primary melanoma: fundamental conceptsHistorical perspective and the emergence of a contemporary paradigmThin melanoma (T1 and T2; less than 2 mm) excision trialsThe Intergroup Melanoma Surgical Trial (T2 and T3 melanomas; 1 to 4 mm)Thicker melanoma (T3 and T4; greater than 2 mm) excision trialsCurrent recommendationsExcisions for histologic variantsTechniques for routine wound closureExcisions for melanomas in unusual or restrictive locationsComplex Closures of Melanoma Excisions; Maurice Y. Nahabedian, Jonathan R. Stretch, Anthony P.TufaroPrinciples of reconstructive surgeryAssessment of the acquired defectReconstructive options for complex woundsDefinitionsUndermining with primary closureSkin graftsComposite graftsLocal flapsRegional flapsFree tissue transferTissue expansionComplex closures: regional considerations and clinical applicationHead and neckTrunkExtremitiesSurgical salvage for extensive and recurrent melanomaLocal Recurrences of Melanoma and Their Management; Kenneth K.Tanabe, Douglas S. Reintgen, Charles M. BalchDefinitionMechanismsRisk factors for local recurrenceSurgical margins and local recurrenceSentinel node biopsy and local recurrenceTiming of local recurrencesLocal recurrence and survivalManagementMucosal Melanoma; Merrick I. Ross, Michael A. HendersonEpidemiologyPathologic features and diagnosisStaging and prognosisMucosal melanomas in the head and neckEpidemiologyClinical presentationDifferential diagnosisPrognosis and natural historyTreatmentMucosal melanomas in the female genital tractVulvar melanomaVaginal melanomaTreatmentAnorectal mucosal melanomasClinical and pathologic featuresTreatmentMucosal melanomas at other sitesUrinary tractEsophagusRole of radiotherapyMelanoma in Children and Teenagers; Julie R. Lange, Ira J. Dunkel, Helen M. Shaw, Arthur J. SoberEpidemiologyCongenital melanomaPrecursors and risk factorsGiant congenital neviSmall and medium congenital neviXeroderma pigmentosumConstitutional risk factorsUltraviolet exposureClinical presentationDiagnosis and surgical managementMedical managementInterferonVaccine trialsChemotherapyOutcomesFollow-up and surveillancePregnancy and the Use of Hormones in Melanoma Patients; Rona M. MacKieNevi and pregnancyPregnancy before melanomaMelanoma before pregnancyMelanoma during pregnancyEffect of pregnancy on disease outcomeTransplacental metastasesTreatment of melanoma during pregnancySurgeryAdjuvant nonsurgical therapy for pregnant womenChemotherapyOral contraception and melanomaUse of oral contraception and subsequent risk of melanomaUse of oral contraceptives after treatment for melanomaHormone replacement therapy and melanomaAppropriate advice on planning pregnancy after treatment for melanomaIn vitro fertilization and melanomaManagement of Regional MetastasesThe Sentinel Lymph Node and Regional Melanoma Micrometastases; Donald L. Morton, Alistair J. Cochran, John F. Thompson, Vernon K. SondakThe history and conceptual basis of sentinel node biopsyAnatomic versus functional definitions of the sentinel lymph nodeIncubator versus marker theoryImmunology of the sentinel nodePathobiology of tumor-induced immunosuppression of the sentinel nodeSentinel node biopsy for staging clinically localized melanomaInterim results of the first Multicenter Selective Lymphadenectomy TrialSurvivalShould lymphatic mapping and sentinel node biopsy be the standard of care for cutaneous melanoma?LM/SNB increases the chance of remaining disease freeLM/SNB is a superior staging technique for identifying appropriate candidates for adjuvant therapyNo noninvasive staging alternative is availableEarly treatment of patients with a positive sentinel node may improve survival"False-positivity" does not apply to the sentinel nodeLM/SNB for melanomas that are not intermediate in thicknessUnresolved issues and ongoing researchThe second Multicenter Selective Lymphadenectomy TrialCarbon particle mappingLymphoscintigraphy in Patients with Melanoma; Roger F. Uren, John F. Thompson, Brendon J. Coventry, Barry E. ChattertonDefinition of a sentinel nodeLymphatic mapping of the skin: early studiesLymphoscintigraphyThe first radiocolloid and early experience with lymphoscintigraphyRadiopharmaceuticals99mTc-labeled colloids99mTc–antimony sulfide colloid99mTc–rhenium sulfide colloid and 99mTc-albumin nanocolloid99mTc-sulfur colloid99mTc–human serum albuminWhat is the ideal radiocolloid?Lymphoscintigraphy for sentinel lymph node biopsy proceduresLymphoscintigraphy techniqueInjecting the tracerImmediate dynamic imagingDelayed static imagingUnexpected lymphatic drainage pathwaysMarking the surface location of the sentinel nodeRadiation dosimetry: risks to the patientRadiation dosimetry: risks to the pregnant patientRadiation dosimetry: risks to attending staffPatterns of lymphatic drainage from the skinTrunkHead and neckThe limbsInterval nodesDrainage to multiple node fieldsComplex lymphatic drainage patternsLymphoscintigraphy in clinically involved node fieldsThe futureNew tracers for lymphatic mappingGamma probes for intraoperative detection of radioactivityGamma cameras for intraoperative imagingAlternate methods of lymphatic mappingIntraoperative Mapping and Sentinel Node Technology in Patients with Melanoma; Jeffrey E. Gershenwald, John F. Thompson, Nicola Mozzillo, Charles M. BalchApproach to clinically negative regional lymph node basins in patients with early-stage primary cutaneous melanomaRationale for lymphatic mapping and sentinel lymph node biopsyTechnique for lymphatic mapping and sentinel lymph node biopsyRole of sentinel lymph node biopsy in pathologic regional lymph node staging: prognostic value of sentinel lymph node pathologic statusEarly resultsPrognostic significancePatterns of failure after negative sentinel lymph node biopsyClinical relevance of submicroscopic diseaseOngoing clinical trials of lymphatic mapping and sentinel lymph node biopsyTechnical planning: overall approachPatient selectionSpecial situationsApproach to patients after previous wide local excisionApproach to patients with irregular lymphatic drainage patternsDesmoplastic histologyComplications and morbidity after lymphatic mapping and sentinel lymph node biopsyTechnical considerations: lymphatic mapping and sentinel lymph node biopsyGeneral operating room positioning strategiesAxillary and Epitrochlear Lymph Node Dissection for Melanoma; Kelly M. McMasters, Sandra L.Wong, Douglas S.Tyler, Charles M. Balch, John F. ThompsonAxillary dissectionAnatomySurgical techniqueOperative approaches to the upper axilla for recurrent or bulky axillary metastasesPostoperative managementComplicationsEpitrochlear dissectionRationaleAnatomySurgical techniqueInguinofemoral, Iliac/Obturator, and Popliteal Lymphadenectomy in Patients with Melanoma; Lisa K. Jacobs, Charles M. Balch, Daniel G. CoitInguinofemoral dissectionIndicationsTechniqueModifications of the classic technique of inguinofemoral lymphadenectomyIliac/obturator (deep pelvic) lymph node dissectionIndicationsBenefitsOperative techniquePostoperative complications: incidence and risk factorsComplications of lymph node dissectionManagement of postoperative complicationsPopliteal dissectionIndicationsOperative techniqueNeck Dissection and Parotidectomy for Melanoma; Anthony P. Tufaro, Suhail K. Mithani, Joseph A. Califano III, Ashok ShahaAnatomySublevelsPatterns of metastatic spread and extent of dissectionNeck dissectionComprehensive neck dissectionSelective neck dissectionComplicationsParotidectomyPreoperative evaluationAnesthesia and positioningTechniqueComplicationsClinical outcomeAdjuvant radiotherapyRecurrent Regional Metastases of Melanoma; Daniel G. Coit, Cristina R. FerroneIn-transit metastasesIncidenceTreatmentAdjuvant therapyPrognosisRecurrent nodal metastases after lymph node dissectionIncidenceTreatmentPrognosisAdjuvant therapyRadiotherapy for Primary and Regional Melanoma; Graham Stevens, Bryan BurmeisterRole of radiotherapy in the management of primary melanomaAdjuvant radiotherapy after surgical excisionResults of curative radiotherapy aloneRadiotherapy for lentigo maligna and lentigo maligna melanomaTreatment recommendations for the use of radiotherapy in primary melanoma and lentigo malignaIllustrative casesRole of radiotherapy in the management of in-transit metastasisTreatment recommendations for the use of radiotherapy for in-transit melanomaIllustrative casesRole of radiotherapy in the management of regional lymph node metastasisAdjuvant postoperative radiotherapy after regional lymph node dissectionResults of adjuvant radiotherapy after complete lymph node dissectionAdjuvant radiotherapy after limited lymph node dissectionPreoperative radiotherapy for bulky nodal diseasePalliative radiotherapy for unresectable regional nodal diseaseTreatment recommendations for the use of radiotherapy in regional nodal metastasisAdjuvant radiotherapy after complete lymph node dissectionAdjuvant radiotherapy after limited lymph node dissection or no dissectionTherapeutic (palliative) radiotherapyIllustrative casesHyperthermic Regional Perfusion for Melanoma of the Limbs; H. Richard Alexander, Jr., Douglas L. Fraker, Alexander M.M. EggermontEpidemiology and natural historyHistorical perspective and early clinical seriesTechnical aspects of isolated limb perfusionMelphalanPharmacokinetics of melphalan in isolated limb perfusionOther chemotherapeutic agentsHyperthermiaTumor necrosis factorToxicity of isolated limb perfusionAdjuvant isolated limb perfusionTherapeutic limb perfusionMelphalan aloneMelphalan and tumor necrosis factorIsolated Limb Infusion for Melanoma; Georgia M. Beasley, Hidde M. Kroon, Merrick I. Ross, Peter C. A. Kam, John F. Thompson, Douglas S. TylerSimilarities and differences between isolated limb infusion and conventional hyperthermic isolated limb perfusionPatient selection for isolated limb infusionTechnical details of the isolated limb infusion procedurePreoperative assessment and managementInsertion and positioning of arterial and venous cathetersProcedure in the operating roomPostoperative carePharmacokinetics of melphalanUse of microdialysis to monitor drug concentrations in limb tissues and tumor deposits during isolated limb infusionLimb and systemic toxicity after isolated limb infusionFactors predicting toxicity after isolated limb infusionClinical results of isolated limb infusionFactors predicting outcome after isolated limb infusionLimb temperatures during isolated limb infusionTourniquet timesInterpretation of prognostic factors dataRepeat isolated limb infusion for disease progression after initial isolated limb infusionComparison with hyperthermic isolated limb perfusionLaboratory studies of isolated limb infusionPotential use of the isolated limb infusion technique to evaluate other drugs and biologic agentsDiagnosis and Local Treatment of Distant MetastasesMetastatic Surveillance and Follow-up of Melanoma Patients; Julie R. Lange, Axel Hauschild, Anne Brecht FranckenGoals of surveillancePatterns of melanoma recurrenceRisk of local and regional recurrenceTime to recurrenceStrategies for active follow-up of melanoma patientsDetection of recurrencesRole of physical examinationPatient educationPatient well-being and follow-upFollow-up schedulesRadiologic studies and laboratory testsScreening for risk of new primary melanomasScreening for other primary cancersCurrent recommendations for surveillanceDiagnosis of Stage IV Melanoma; Michael B. Atkins, Axel Hauschild, Richard L.Wahl, Charles M. BalchTiming of distant metastasisPattern of metastasisPrognosis and prognostic factorsSites of distant metastasesNumber of metastatic sitesElevated serum lactate dehydrogenaseDuration of remissionPerformance statusOther prognostic factorsClinical evaluation of metastasisHistory and physical examinationLaboratory tests/biomarkersRadiologic testsPathologic testsSites of distant metastasesSkin, subcutaneous tissues, and distant lymph nodesLung, pleura, and mediastinumBrain and spinal cordGastrointestinal tractLiver, biliary tract, and spleenBoneKidneys and urinary tractHeart and pericardiumPancreasPeritoneum and mesenteryEndocrine organsBreastOvaries, uterus, and placentaTestes and penisOral cavity, pharynx, and larynxEye and orbitCutaneous melanosisMetastatic melanoma from an unknown primary siteSurveillance in patients who have localized melanomaSurgical Excision of Distant Melanoma Metastases; John F. Thompson, Donald L. Morton, Charles M. Balch, Merrick I. RossCurrent status of surgery for stage IV melanomaRelationships between tumor burden, immune function, and surgical treatmentSelection of patients and prognostic factorsOutcomes after surgical resection of melanoma metastases at specific sitesSkin, subcutaneous tissue, and lymph nodesLung, trachea, and bronchiBrain and spinal cordGastrointestinal tractLiver, biliary tract, and spleenBoneKidney and urinary tractHeart and pericardiumEndocrine organsBreastOvaries, uterus, and vaginaTestes and penisOral cavity and pharynxEye and orbitRadiotherapy for Distant Metastases and Clinical Radiobiology of Melanoma; Graham Stevens, Angela Hong, Michael J. McKayRadiotherapy for distant metastasesSkin and subcutaneous metastasesLymph node metastasesBrain metastasesMalignant spinal cord compressionBone metastasesSites irradiated less commonlyDeveloping sites for focused radiation treatmentIllustrative casesClinical radiobiology of melanomaBiologic factors affecting the ionizing radiation response of melanomaIntrinsic cellular radiosensitivityTumor oxygenation and microenvironmentalFactorsTumor cell proliferation kineticsNumber of clonogenic tumor cellsInfluence of melanization on radiosensitivityHost factors in melanoma response and outcomeFuture possibilitiesMethods to improve the response of melanoma cellsMethods to improve the delivery of radiation to melanoma metastasesMultidisciplinary Management of CNS Melanoma Metastases; Kim A. Margolin, George M. Cannon, Minesh P. Mehta, Michael Y. ChenRisk factors and prognosisClinical featuresNeurosurgical management of brain metastasisRadiotherapeutic and radiosurgical management of melanoma metastatic to the brain or spineWhole-brain radiotherapyWhole-brain radiotherapy aloneSurgery followed by whole-brain radiotherapyStereotactic radiosurgerySystemic therapy for melanoma metastatic to the central nervous systemSystemic therapy considerations after adequate control of the central nervous systemPalliative approachAggressive approachInvestigational approachSystemic Treatment of Metastatic DiseaseAdjuvant Systemic Therapy for High-Risk Melanoma Patients; John M. Kirkwood, Vernon K. Sondak, Peter Hersey, Helen GogasWho should be considered for adjuvant therapy?Chemotherapy alone or in multiagent combinations as adjuvant therapy for melanomaMicrobial immunostimulantsBacillus Calmette-GuérinCorynebacterium parvumLevamisoleHormonal therapyMelanoma vaccines tested in phase III adjuvant trialsAdjuvant interferons as postoperative adjuvant therapy for melanomaAdjuvant applications of interferon-alpha-2Adjuvant applications of interferon-gammaEmerging new modalities of adjuvant therapyBiomarkers of prognosis and responseChemotherapy-Based Treatment of Metastatic Melanoma; Michael B. Atkins, Mark R. Middleton, Paul B. ChapmanSingle-agent chemotherapyDacarbazine and temozolomideNitrosoureasPlatinumsMicrotubule toxinsCombination cytotoxic chemotherapyNitrosourea combinationsTaxane-based combination therapyCisplatin-based combination therapyChemohormonal therapyBiochemotherapyInterferon alpha–based biochemotherapy regimensInterleukin-2–based regimensInterleukin-2 and DTIC/temozolomide combinationsCisplatin and interleukin-2–based biochemotherapy regimensInpatient concurrent biochemotherapy regimensPhase III biochemotherapy trialsOther biochemotherapy investigationsNon–interleukin-2 or interferon-based biochemotherapy combinationsChemotherapy and antiangiogenic or targeted therapyAntiangiogenic agentsAntiapoptosis-inducing agentsSelection of future phase III trialsInterferon Therapy for Melanoma; Ernest C. Borden, Stergios J. Moschos, John M. KirkwoodEndogenous interferons as part of the host response to cancerThe family of interferon proteins and signaling activationMechanisms of antitumor action in melanomaSignaling by interferonsCellular mechanisms of action of interferonsInterferon-alpha-2 in the treatment of melanomaThe future of interferons in melanoma biology and therapyInterleukins and Cellular Therapies for Melanoma; Douglas J. SchwartzentruberPharmacology of interleukin-2Immunologic activity of interleukin-2Systemic effects of interleukin-2Clinical efficacy of high-dose interleukin-2 aloneClinical efficacy of alternate doses, routes, and schedules of interleukin-2 aloneClinical efficacy of interleukin-2 combined with interferon-alphaClinical efficacy of interleukin-2 combined with other cytokines, immune modulators, antibodies, or vaccinesAgents to reduce the toxicity of interleukin-2Predictors of clinical responseOther cytokines for treatment of metastatic melanomaClinical efficacy of interleukin-2 combined with cellular therapyMelanoma Vaccines; Jedd D.Wolchok, Jeffrey S.WeberTumor immunologyAntigen discoveryAdjuvantsVaccine approachesCell vaccinesTransduced cell vaccinesHLA-restricted melanoma-associated antigenic peptidesGanglioside vaccinesAntiidiotypic monoclonal antibodies mimicking ganglioside antigensProtein antigensHeat-shock protein–based vaccinesDNA vaccinationDendritic cell vaccinesRecombinant viral vaccinesCombination strategies and the future of melanoma vaccinesImmune Modulators in the Treatment of Patients with Melanoma; James P. Allison, F. Stephen Hodi, Yvonne M. Saenger, Jedd D. WolchokBiology of CTLA-4–mediated immune inhibitionPreclinical development of anti-CTLA-4 as an anticancer agentAnti-CTLA-4: clinical experience in melanomaEfficacy of CTLA-4 blockade: summary of clinical trials to dateCTLA-4 blockade and immune-related adverse eventsKinetics of responsePatient selection and predictors of toxicity and antitumor responseDose and schedule of anti-CTLA-4 administrationCorrelative immunologic studiesVaccination strategies in combination with CTLA-4 blockadeCombination of CTLA-4 blockade and GM-CSF vaccination in murine modelsClinical investigation of combination CTLA-4 blockade and autologous GM-CSF–secreting tumor vaccinationCTLA-4 blockade with peptide vaccinesOther CTLA-4 antibody and immunotherapy combinationsMelanoma-Specific Targeted Therapies; Paul B. Chapman, David B. Solit, Keith T. FlahertyTargeting cell surface moleculesTargeting receptor tyrosine kinases expressed in melanomaMonoclonal antibodiesTargeting intracellular moleculesThe mitogen-activated protein kinase pathway in melanomaDrugs that inhibit BRAFHsp90 inhibitorsDrugs that inhibit MEKTargeting PI3/AKT pathwayAngiogenesis inhibition in melanomaBiology of MelanomaGenetics and Molecular Pathology of Melanoma; Boris C. Bastian, Daniel Pinkel, Amaya VirosDistinct patterns of epidemiologic, clinical, and histopathologic features in melanomaEmerging melanoma subtypes based on genotypephenotype correlationsMelanomas on sun-exposed sitesMelanomas on relatively or absolutely UV-protected sitesMelanocytic tumors arising without associations to epithelial structuresBiology of Melanocytes and Primary Melanoma; Glenn Merlino, Vincent J. HearingDevelopment of melanoblastsRegulation of specificationRegulation of migrationRegulation of survival and proliferationDifferentiation of melanocytesRegulation of differentiationRegulation of survivalMelanomagenesisFrom melanocyte to melanoma: a multistep processMolecular genetics: early lessons from familial and sporadic melanomaMelanoma: a consequence of homeostatic disruptionMelanoma: cell of originMelanoma and the environmentSun exposure and epidemiologyPhotobiology and melanomaBiology of Melanoma Metastasis; Menashe Bar-Eli, Isaiah J. FidlerThe pathogenesis of melanoma metastasisTranscriptional regulation of melanoma progressionRole of AP-2-α in melanoma progressionRole of CREB/ATF-1 in melanoma progressionInvolvement of ATF-2 in melanoma progressionSNAIL: its regulatory pathway in melanomaMITF: its role in melanoma progressionRegulation of melanoma metastasis by the tumor microenvironmentRole of platelet-activating factor receptorPotential therapeutic approaches to inhibiting melanoma metastasisUsing fully humanized antibodies to MCAM/MUC18 to inhibit tumor growth and metastasis of human melanomaUsing fully humanized neutralizing antibodies to interleukin-8 (ABX-IL-8) to inhibit angiogenesis, tumor growth, and metastasis of human melanomaImmunology of Melanoma; Suzanne L.Topalian, Lieping Chen, Janis M.Taube, Paul F. Robbins, Jedd D.Wolchok, Alan N. HoughtonInnate immunityAdaptive immunityMelanoma antigensGeneral principles for identification of tumor antigens recognized by T cells and antibodiesNonmutated self-antigensMutant melanoma antigens Altered peptide ligands: enhancing the immunogenicity of low-affinity melanoma epitopesExperimental modelsImmune regulation and toleranceCostimulatory/coinhibitory receptorsRegulatory T cellsCytokinesImplications for immunotherapyBiomarkers for Melanoma; Elizabeth A. Grimm, Dave S.B. Hoon, Lyn McDivitt DuncanPotential clinical impact of melanoma biomarkersMelanoma heterogeneityMelanoma biomarker discovery and validation processBiomarkers in early-stage melanomaMolecular markers in primary cutaneous melanomaBiomarkers for later-stage melanomaMolecular markers in sentinel lymph nodesMolecular markers in bloodMolecular markers in metastatic tumorsAdditional CreditsIndex

Read more less

Book SynopsisThe inspirational true story of one man's struggle against cancer, as he bravely undergoes an experimental treatment that may offer new hope to cancer patients everywhere.

Read more less

Book SynopsisThis book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.Trade ReviewFrom the reviews:“This is a comprehensive overview of biomarkers as they relate to pathogenesis and clinical utility in the diagnosis, staging, and treatment of melanoma. … The audience is practitioners specializing in melanoma, including dermatologists, surgeons, and oncologists, as well as researchers in the field. … book broadly explores the role of molecular diagnostic techniques and specific biomarkers which may serve to facilitate more accurate diagnoses and identify early-stage melanoma patients with high risk for metastasis. … I highly recommend this book for melanoma clinicians and researchers.” (Susan M. Swetter, Doody’s Book Reviews, July, 2012)Table of ContentsTable of Contents:1. Introduction to Diagnostic and Prognostic Biomarkers and Therapeutic Targets in MelanomaMichael J. Murphy2. Diagnostic and Prognostic Biomarkers in Melanoma: Current State of Play Jochen Utikal, Jürgen C. Becker, and Selma Ugurel3. Molecular Pathogenesis of Melanoma: Established and Novel PathwaysPaolo Antonio Ascierto, Maria Libera Ascierto, Mariaelena Capone, Zendee Elaba, Michael J. Murphy, and Giuseppe Palmieri4. Staging of MelanomaZendee Elaba, Michael J. Murphy, Philip Kerr, and Jane M. Grant-Kels 5. Clinical and Histopathological Parameters in MelanomaCheryl Bilinski, Avery LaChance, and Michael J. Murphy6. Genetic/Epigenetic Biomarkers: Distinction of Melanoma from Other Melanocytic NeoplasmsMinoru Takata 7. mRNA Biomarkers in MelanomaGiovanna Chiorino and Maria Scatolini8. Epigenetic Biomarkers in MelanomaSuhu Liu, Suping Ren, Paul M. Howell Jr., and Adam I. Riker9. microRNA Biomarkers in MelanomaJim Kozubek, Faseeha Altaf and Soheil S. Dadras10. MicroRNAs as Biomarkers and Therapeutic Targets in MelanomaDaniel W. Mueller, Anja K. Bosserhoff11. Mitochondrial DNA Biomarkers in MelanomaMark L. Steinberg12. Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (A) DiagnosisSteven J. Ohsie, Basil A. Horst, Alister Cochran, and Scott W. Binder13. Tissue-Based Protein Biomarkers in Melanoma: Immunohistochemistry: (B) PrognosticationBasil A. Horst, Steven J. Ohsie, Alister Cochran, and Scott W. Binder14. Tissue-Based Protein Biomarkers in Melanoma: Mass Spectrometry-Based StrategiesMichael J. Murphy, Karim Rezaul, and David K. Han15. Serological Biomarkers in MelanomaMel Ziman, Michael Millward, Robert Pearce, and Mark Lee16. Molecular Markers of Lymph Node Disease in MelanomaSandro Pasquali, Augustinus P.T. van der Ploeg, and Simone Mocellin17. Melanoma Cell Propagation: Cancer Stem Cell, Clonal Evolution and Interconversion Models of TumorigenicityQiuzhen Liu, Marianna Sabatino, David F. Stroncek, Ping Jin, Francesco M. Marincola, and Ena Wang 18. Surgical Management of Melanoma: Concept of Field Cancerization and Molecular Evaluation of Tissue MarginsAmanda Phelps and Michael J. Murphy19. Chemotherapy for MelanomaHedwig Stanisz, Thomas Vogt, and Knuth Rass20. Molecular-Targeted Therapy for MelanomaAlessia E. Russo, Ylenia Bevelacqua, Andrea Marconi, Andrea Veronesi, and Massimo Libra21. Anti-Angiogenesis Therapy for MelanomaRoberta Ferraldeschi and Paul Lorigan22. Immunological Biomarkers and Immunotherapy for MelanomaJochen T. Schaefer23. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma: An OverviewAhmad A. Tarhini and John M. Kirkwood

Read more less

Book SynopsisAfter the intense experience and range of emotion that comes with surgery, radiation, or chemotherapy (or all three), cancer patients often find themselves with little or no guidance when it comes to their health post-treatment. After Cancer Care, from Drs. Gerald Lemole, Pallav Mehta, and Dwight McKee, is the much-needed authoritative, approachable guide that fills this gap. According to Drs. Lemole, Mehta, and McKee, your choices in diet, exercise, and even relationships can help determine your propensity for relapse. With more than three decades of post-cancer-care experience, the doctors break down this science into palatable, practical takeaways so that readers will drastically improve their quality of life to enjoy many years of cancer-free serenity.

Read more less

Book SynopsisThis volume presents a snapshot of some of the most important ongoing research in cancer. With cancer as the second leading cause of death worldwide, extensive research is going on globally to decipher the molecular mechanism underlying cancer that will help in finding better targets for drug therapy. The book brings together new research on molecular mechanism and cancer therapeutics in one place. With chapters from experts in their respective fields, chapters cover molecular mechanisms, etiology, prognosis, detection, and treatment of cancer. Emphasis has been given to the intricate mechanism behind the deregulation of cell division, disruption of cell cycle check points, mutation in oncogenes and tumor suppressor genes, apoptosis, and erratic cell signaling. The book discusses in detail topics such as angiogenesis and tumor microenvironment, which are increasingly receiving attention, especially in the field of neoplastic vascularization and metastasis. The book also includes chapters detailing the current understanding and the future perspective of cancer stem cells. Trade Review“One of the few books that sheds light on the causes and mechanisms of the disease itself as well as the possible therapeutic aspects. The book contains intricately woven chapters on cell cycle checkpoints on cancer, oncogenes, tumor suppressor genes, apoptosis, cell signaling, angiogenesis and metastasis. The modern approaches toward cancer diagnosis and therapy, like cancer stem cell, immunotherapy, chemotherapy, and nanoparticle-based therapy, have also been thoroughly covered. The contributors of each and every chapter are experts in their respective field and have summarized their research findings in a very concise manner. The best part of the book is that the chapters have been grouped into major divisions to have continuity and synchronization among them. The volume can be used by students and researchers who are working in the field of cancer. It covers new approaches toward cancer treatment and therefore may be useful handbook for clinicians. Overall, this informative volume covers the present knowledge and future direction on the field of cancer research.”— Dr. Naibedya Chattopadhyay, Scientist G, CSIR-Central Drug Research Institute, Lucknow, IndiaTable of ContentsGenetic Instability in Cancer. Oncogenesis and Telomerase Activity in Cancer. Cell Cycle Checkpoints in Cancer. Angiogenesis, Its Importance and Implication in Tumor Growth and Progression and in Anticancer Therapy: An Update. The Tumor Microenvironment and Metastasis. Apoptosis: A Regulatory Mechanism in Cancer. Cytoplasmic Signaling Circuitry: An Important Trait of Cancer. Cancer: An Overview of Risk Factors. Single Nucleotide Polymorphisms as Susceptibility Markers for Cancer. Dietary Phytochemicals in the Prevention and Therapy of Cancer: Modulation of Molecular Targets. Health Benefits and Preventive Effects of Common Beverages in Cancer. Cancer Chemotherapy. Non-Coding RNAs: The New Reins in Malignancies. Epigenetics in Cancer Prevention and Therapy: Role of Phytochemicals. Cancer Stem Cell: Current Understanding and Future Perspectives. Tumor Microenvironment and Cancer Stem Cells: Therapeutic Potential of Epigenetic Inhibitors to Target CSCs. Nanoparticles in Cancer Therapy. Cancer Immunotherapy: Extending New Horizons in Cancer Treatment.

Read more less

Book SynopsisThis book provides a practical, superbly illustrated guide to the clinical diagnosis of eyelid tumors and the surgical procedures used for tumor excision and eyelid reconstruction. In this completely revised and updated Second Edition, there are new chapters on pathology and radiosurgery, procedures have been amended to reflect current practice, all the surgical illustrations have been redrawn in full color, and selected clinical photographs have been added or replaced.The first section of the book covers differential diagnosis and features over 100 full color photographs of benign and malignant eyelid tumors and inflammatory conditions, accompanied by concise descriptions of the clinical presentation and the course of these lesions. This section is designed to enable the clinician to distinguish accurately lesions requiring biopsy and/or surgical removal from those that should be treated medically or observed for changes.In the second section, the author describes the surgical anatomy of the eyelids and surrounding structures, and provides currently accepted procedures for eyelid tumor biopsies, the most effective techniques for tumor removal, and upper and lower lid reconstruction. Key steps are illustrated by over 200 full color drawings and photographs.With its emphasis on the more common conditions, and its clear, user-friendly and practical approach, Eyelid Tumors is a valuable source of reference for ophthalmic clinicians and surgeons, plastic and reconstructive surgeons, dermatologists and pathologists.Trade ReviewWell written, practical and concise. Excellent colour illustrations and photographs fill this book and complement its easily readable text...an exceptional resource in managing patients with eyelid tumors.—Journal of Cosmetic and Laser SurgeryTable of ContentsDiagnosis and Management: Differential Diagnosis of Eyelid Tumours. Malignant Tumours. Benign Tumours and Related Conditions. Treatment of Eyelid Tumors. Reconstruction of the Eyelids: Surgical Anatomy. General Principles of Eyelid Reconstruction and Radiosurgery. Lower Eyelid Reconstruction. Upper Eyelid Reconstruction. Repair of Defects that do not involve Eyelid Margins. Reconstruction of the Medial and Lateral Canthi.

Read more less

Book SynopsisIn Europe and the USA we have a 40-50% chance of getting cancer at some time in our lives. So what do you do if you are diagnosed with the disease? The harshness of orthodox treatments (surgery, radiation and chemotherapy) are well-known. Their use is widespread, but their results are not impressive. Faced with these options, informed patients are increasingly seeking out alternative or complementary strategies to take control of their own healing. This book provides an overview of them. Jonathan Chamberlain watched his wife suffer and eventually die - both from her cancer and from the direct effects of the orthodox treatments she had undergone. This experience led him on a journey in search of other methods of overcoming cancer. What he discovered stunned him. There are cures out there - dozens of them - many offering very good chances of recovery. In Cancer Recovery Guide Chamberlain presents 15 simple, practical strategies for becoming well again. These strategies are grouped in three families: those relating to the mind and the emotions (did you know stress makes cancers more aggressive?) ; those relating to the health of the whole body (cancer cannot survive in a tissue environment that is truly healthy); and those that focus on directly attacking the cancer tumours. The personal stories cited throughout the book testify to the curative possibilities of the strategies presented.Trade Review'Mr. Chamberlain has a voice that is at once humble and powerful'.. He speaks from the heart, but clearly wants you to use your head. Good combination.' - DOCTOR YOURSELF NEWSLETTER 'I now can recommend your book to the people in my support group, as "the" book to read. You have covered just about everything.' - John Thompson, cancer patient 'This book tells me everything I want to know. Why didn't my doctor tell me this?' - Rev. Bill Newbern, cancer patientTable of ContentsAcknowledgements Preface Introduction: Understanding the Basics The 15 Strategies Strategy 1: Embrace Hope - Cancer is Curable Strategy 2: Harness the Healing Power of the Mind Strategy 3: Love and Forgive Yourself and Others Strategy 4: Relax and Laugh Strategy 5: Detox the Body Strategy 6: Oxidize the Body Strategy 7: Alkalize the Body Strategy 8: Empower the Body Strategy 9: Feed the Body with the Right Nutrients Strategy 10: Cut the Cancer's Energy Supply Strategy 11: Interfere with the Cancer Cell's DNA Strategy 12: Induce Cancer Cell Suicide Strategy 13: Attack the Tumour Strategy 14: Attack the Causes of Cancer Strategy 15: Open Yourself to Possibilities Further Reading Index

Read more less

Book SynopsisThis is my Brain Cancer Memoir Tale. For years now I've blindly followed suit. Late 2018 they found a lemon in the back of my caput and took it out for all the world to look. They took some of my best moves, left me a shuddering hulk and stopped me walking too far in front. To fail and fail and fail, I've fallen back into my castle of frail. The Holy Grail may well be far away, but my broken Brain still remains today. Symptoms and side-effects and explanations for why I fall over so much. I'm not the man I was before. It takes me a little time to do my thing, I’m sure, but slowly I'll get to where I was before.

Read more less

Book Synopsis

Read more less

Book SynopsisBased on DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, Eleventh Edition, this comprehensive review book covers the entire specialty of oncology, including new or expanded coverage of molecular biology; epidemiology and etiology; screen and prevention; genetics; clinical trials; and immunotherapy. Inside, readers will discover hundreds of multiple-choice and case-based questions, along with detailed answers and explanations to help explain the how and why behind each correct response. The ideal way to maximize exam scores for today’s student and residents!Learning and review features include: Hundreds of multiple-choice and case-based questions to build comprehension and improve retention. All topics cross-referenced to the latest edition of DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology, Eleventh Edition. Material on all aspects of oncology, including medical, radiation and surgical oncology, as well as hematology/oncology issues Enrich Your eBook Reading Experience Read directly on your preferred device(s),such as computer, tablet, or smartphone. Easily convert to audiobook,powering your content with natural language text-to-speech.

Read more less

Book SynopsisThis volume provides a comprehensive and up-to-date account of the use of MRI and CT to identify and characterize developmental anomalies and acquired diseases of the female genital tract. Both benign and malignant diseases are considered in depth, and detailed attention is also paid to normal anatomic findings and variants. Further individual chapters focus on the patient with pelvic pain and the use of MRI for pelvimetry during pregnancy and the evaluation of fertility. Compared with the first edition, chapters have been either newly written by different authors or updated to reflect intervening progress; in addition, imaging of the placenta is now covered. Throughout, emphasis is placed on the most recent diagnostic and technical advances, and the text is complemented by many detailed and informative illustrations. All of the authors are acknowledged experts in diagnostic imaging of the female pelvis, and the volume will prove an invaluable aid to everyone with an interest in this field.Table of Contents1. Clinical Anatomy of the Female Pelvis2. MR and CT Techniques3. Uterus: Normal Findings4. Congenital Malformations of the Uterus5. Benign Uterine Lesions6. Cervical Cancer7. Endometrial Cancer8. Uterine Sarcomas9. Ovaries and Fallopian tubes: Normal findings and Anomalies10. Adnexal Masses: Benign Ovarian Lesions and Characterization11. Adnexal Masses: Characterization of Benign Adnexal Masses12. CT and MRI in Ovarian Carcinoma13. Endometriosis14. Vagina and Vulva15. Imaging of Lymph Nodes16. Acute and Chronic Pelvic Pain Disorders17. MRI of the pelvic floor18. Evaluation of infertility19. MR Pelvimetry20. MR Imaging of the Placenta

Read more less

Book SynopsisNow in its second edition, this popular text remains a comprehensive study and review aid for the radiation oncology trainee and practicing radiation oncologist. The updated Radiation Oncology Study Guide, 2e maintains its robust Q&A format, and has been comprehensively updated to include the latest staging information and treatment methods. Answer rationales have been modified to a more readable, high yield bulleted format.Each chapter covers a major disease site and is divided into two main parts: Questions & Answers and Rationale. Questions review the scope of clinical practice, spanning from initial presentation to complications of treatment. General content and work-up questions emphasize “pearls” of epidemiology, anatomy, pathology, clinical presentation, and staging. Treatment content questions not only review evidence-based data guiding treatment recommendations, but also practical aspects of radiation treatment planning, pertinent radiobiology and physics, and complications of treatment. This book is an ideal resource for physicians-in-training to prepare for initial written and oral exams and physicians in practice to maintain their skills and prepare for maintenance of certification longitudinal and written exams.Table of Contents1. Central Nervous System Tumors a. Adult high grade gliomas b. Adult low grade gliomas c. Pediatric gliomas 2. Skin Cancer a. Melanoma b. Non-melanomatous cancers 3. Head and Neck Cancer a. Nasopharynx cancer b. Nasal cavity and paranasal sinus cancer c. Oropharyngeal cancer d. Cancer of the larynx and hypopharynx e. Cancer of the lip and oral cavity f. Thyroid cancer g. Salivary gland tumors h. Unknown H&N primary 4. Lung Cancer a. Non-small cell lung cancer b. Small cell lung cancer c. Mesothelioma 5. Tumors of the Mediastinum a. Thymoma and Thymic carcinoma 6. Breast Cancer a. DCIS/ LCIS b. Early-stage invasive c. Locally advanced invasive d. Post-mastectomy 7. Upper Gastrointestinal Cancers a. Esophageal cancers b. Gastric cancers c. Small intestine cancers 8. Lower Gastrointestinal Cancers a. Pancreatic cancer b. Hepatobiliary cancer c. Colorectal cancer d. Anal cancer 9. Cancers of the Urinary System a. Renal cell carcinoma b. Bladder cancer 10. Male Genitourinary Cancers a. Prostate cancer b. Penile cancer c. Testicular cancer 11. Gynecological Cancers a. Endometrial cancer b. Cervical cancer c. Ovarian cancer d. Vaginal cancer e. Vulvar cancer 12. Lymphomas a. Hodgkin’s Lymphoma b. Non-Hodgkin’s Lymphoma c. Multiple myeloma and plasmacytomas d. Mycosis Fungoides 13. Leukemia a. Transplant/Total Body Irradiation 14. Soft Tissue Sarcomas and Bone tumors 15. Pediatric non-CNS Tumors a. Wilms’ Tumor b. Neuroblastoma c. Rhabdomyosarcoma d. Ewing’s sarcoma e. Hodgkin’s lymphoma f. Retinoblastoma 16. Clinical Physics and Radiobiology a. Electron therapy b. Proton therapy c. SRS/SBRT d. IGRT e. Immunotherapy f. Precision Oncology 17. Palliation a. Spinal cord compression b. Brain metastases c. Bone metastases d. Super vena cava syndrome e. Dysphagia f. Hemostatic Radiotherapy g. Oligometastatic disease

Read more less

Book SynopsisThis is a comprehensive guide for patient preparation, image acquisition, and image interpretation for PET/CT and PET/MR, specifically relevant to melanoma and sarcoma. Imaging specialists and referring physicians are often not as intimately aware of the particulars of PET imaging in management of patients with melanoma and sarcoma and how it could affect their treatment. This book fills that gap by presenting comprehensive information on melanoma, sarcoma, and the role of PET imaging in their diagnosis and management. The book begins by covering the basics of imaging for practicing physicians and trainees. Expert authors then further cover the biological concepts of melanoma and sarcoma and how they relate to imaging, particularly PET, the oncologist’s perspective, and the surgeon’s perspective on imaging for both the imaging specialist and the referring physician. Chapters review topics such as: PET/CT and PET/MR images in melanoma and sarcoma from a systemic approach, false-positives, false-negatives, pitfalls, and molecular imaging beyond PET. Images are used extensively throughout to enhance understanding for the reader. This is an ideal guide for radiologists, nuclear medicine physicians, oncologists, surgeons, trainees and technologists. Table of ContentsPrefaceDedication Chapter 1: What is Positron Emission Tomography? Chapter 2: Patient Preparation for FDG PET with an Emphasis on Soft Tissue Sarcoma and Melanoma: What Matters (and What Doesn’t) Chapter 3: PET/CT and PET/MR in Soft Tissue Sarcoma and Melanoma Patients: What to Image and How to Image It Chapter 4: Systematic Approach to Evaluation of Melanoma and Sarcoma with PET Chapter 5: Review of PET/CT Images in Melanoma and Sarcoma: False-Positives, False-Negatives and Pitfalls Chapter 6: PET beyond pictures Chapter 7: The Role of PET/CT in Melanoma Patients: A Surgeon’s Perspective Chapter 8: PET in Sarcoma – Surgeons Point of View Chapter 9: FDG PET in the Diagnosis and Management of Pediatric and Adolescent Sarcomas Chapter 10: Beyond FDG: Novel Radiotracers for PET Imaging of Melanoma and Sarcoma Chapter 11: Future Directions of PET and Molecular Imaging and Therapy with an Emphasis on Melanoma and Sarcoma

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisThis book is designed to capture and clinically review the comprehensive database of clinical research articles that support and do not support the utilization of a variety of dietary supplements and other complementary medicines that physicians are exposed to in their daily practice. The growing list of CAM products that could interfere with surgery (anesthesia, bleeding, outcomes…) and/or conventional medicines is very large and is provided in each section of the book. Additionally, the list of dietary supplements that could be utilized to improve quality of life for breast cancer patients is also emphasized. The various sub-specialty groups in breast are adequately represented, which allows for a physician to rapidly and thoroughly investigate their topic of interest regardless of whether the topic is prevention, treatment, or a specific side effect of treatment.The practical nature of Integrative Medicine for Breast Cancer: An Evidence-Based Assessment cannot be overstated. Chapters include a general overview of the CAM agent, whether or not it has data in medicine and oncology, and a list of potential drug interactions and specific clinical scenarios where it can be utilized or discouraged in the specialty. Thus, this book will become the gold standard evidence based text for use in teaching, not only for the students interested in oncology and breast cancer, but for all current oncology health providers.Table of ContentsChapter 1 .- Introduction.- Chapter 2 25+ Observations over 25+ years for Surviving & Thriving in the Dietary Supplement Quality Control &/or Perception vs. Reality World.- Chapter 3.- The Ideal 7-Step Breast Cancer Diet, Lifestyle & Dietary Supplements Program for Prevention/Recurrence: Heart Healthy=Breast Healthy.- Chapter 4.- S.A.M & Breast Cancer-Focus on Statins, Red Yeast Rice, Sterols & Other Integrative Cholesterol Medicines: The Real “Natural” Options.- Chapter 5 S.A.M. & BREAST CANCER-Focus on Aspirin & Other Integrative Aspirin-like Medicines: The Real “Natural” Options.- Chapter 6 S.A.M. & BREAST CANCER-Focus on Metformin & Other Integrative Metformin-Mimic Medicines: The Real “Natural” Options.- Chapter 7 Rapid Review of Breast Cancer Treatment Side Effects and Dietary Supplement/Integrative Options from A to Z: What helps, harms, or does nothing.- Chapter 8 Supplements/Diet/Other Integrative Method Vernacular & Controversies from A to Z: What is the latest or greatest, or not so great.

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book Synopsis

Read more less

Book SynopsisTNM Atlas Der maßgebende Atlas zur aktuellen TNM Klassifikation — jetzt mit noch mehr Illustrationen Das TNM System ist das weltweit am häufigsten verwendete Werkzeug, die Ausbreitung einer Krebserkrankung zu klassifizieren und in Stadien einzuteilen. Herausgegeben in Zusammenarbeit mit der UICC (Union for International Cancer Control) stellt der TNM Atlas, Siebte Auflage, die illustrierte Version der TNM Klassifikation, Achte Auflage, dar. Dieses Werk unterstützt mit erstklassigen anatomischen Darstellungen bei der praktischen Anwendung des TNM Klassifikationssystems. T- und N-Kategorien werden mit klaren und einfach zu verstehenden Abbildungen illustriert, ergänzt durch ausgewählte tomographische Aufnahmen aus der klinischen Praxis. Inhaltlich vollkommen überarbeitet, basierend auf der aktuellen TMN Klassifikation Mit mehr als 300 farbigen Abbildungen, die die anatomischen Besonderheiten jeder Tumorerkrankung akkurat und detailgetreu darstellen Unverzichtbares Werk nicht nur für die Diagnose, sondern auch für Ausbildung und für Aufklärungsgespräche mit Patient⋆innen Die in Genf ansässige UICC ist eine weltweit anerkannte Organisation, deren zentrale Aufgabe die Tumorklassifikation und Krebsbekämpfung ist. Ihr TNM Atlas ist ein wertvolles Nachschlagewerk für Onkolog⋆innen, Chirurg⋆innen, Patholog⋆innen, Mitarbeitende in Krebsregistern und onkologisches Pflegepersonal, sowie für Krebsforschungsinstitute und entsprechende staatliche Einrichtungen und nichtstaatliche Organisationen.Table of ContentsVorwort Zur Siebten Auflage vii Danksagung viii Mitwirkende Der Siebten Auflage ix Erläuternde Vorbemerkungen x Kopf- Und Halstumoren 1 Lippen Und Mundhöhle 17 Pharynx 28 Larynx 50 Nasenhöhle Und Nasennebenhöhlen 60 Unbekannter Primärtumor Mit Metastasen Der Halslymphknoten 70 Malignes Melanom Des Oberen Aerodigestivtrakts 74 Grosse Speicheldrüsen 77 Schilddrüse 82 Tumoren Des Verdauungstrakts 89 Ösophagus Einschliesslich Ösophagogastraler Übergang 90 Magen 98 Dünndarm 105 Appendix 110 Kolon Und Rektum 116 Analkanal 126 Leber – Hepatozelluläres Karzinom 132 Leber – Intrahepatische Gallengänge 137 Gallenblase 141 Perihiläre Extrahepatische Gallengänge 147 Distale Extrahepatische Gallengänge 151 Ampulla Vateri 154 Pankreas 161 Gut Differenzierte Neuroendokrine Tumoren Des Gastrointestinaltrakts 167 Gut Differenzierte Neuroendokrine Tumoren Des Pankreas 179 Lungen- Pleura- Und Thymustumoren 183 Lunge 184 Pleuramesotheliom 196 Thymustumoren 203 Knochen- Und Weichteiltumoren 213 Knochen 214 Weichteile 221 Gastrointestinaler Stromatumor 228 Hauttumoren 231 Karzinom Der Haut 236 Hautkarzinome Des Kopf-hals-bereichs 240 Karzinom Der Haut Des Augenlids 249 Malignes Melanom Der Haut 256 Merkelzellkarzinom Der Haut 267 Mammatumoren 271 Gynäkologische Tumoren 291 Vulva 292 Vagina 298 Cervix Uteri 305 Uterus Endometrium 315 Uterus – Uterussarkome 321 Ovar Tuba Uterina Und Primäres Peritonealkarzinom 329 Trophoblastäre Schwangerschaftstumoren 337 Urologische Tumoren 341 Penis 342 Prostata 350 Hoden 358 Niere 375 Nierenbecken Und Harnleiter 384 Harnblase 390 Urethra 396 Nebennierenrindentumoren 406 Hodgkin-lymphome 410 Non-hodgkin-lymphome 425

Read more less

Book SynopsisThe mathematical models in this book are concerned with a variety of approaches to the manner in which the clinical radiologic treatment of human neoplasms can be improved. These improvements comprise ways of delivering radiation to the malignan­ cies so as to create considerable damage to tumor cells while sparing neighboring normal tissues. There is no unique way of dealing with these improvements. Accord­ ingly, in this book a number of different presentations are given. Each presentation has as its goal some aspect of the improvement, or optimization, of radiotherapy. This book is a collection of current ideas concerned with the optimization of human cancer radiotherapy. It is hoped that readers will build on this collection and develop superior approaches for the understanding of the ways to improve therapy. The author owes a special debt of thanks to Kathy Prindle who breezed through the typing of this book with considerable dexterity. TABLE OF CONTENTS Chapter GENERAL INTRODUCTION 1. 1 Introduction 1 1. 2 History of Cancer and its Treatment by Radiotherapy 8 1. 3 Some Mathematical Models of Tumor Growth 12 1. 4 Spatial Distribution of the Radiation Dose 20 Chapter 2 SURVIVAL CURVES FROM STATISTICAL MODELS 24 2. 1 Introduction 24 2. 2 The Target Model 26 2. 3 Single-hit-to-kill Model 27 2. 4 Multitarget, Single-hit Survival 29 2. 5 Multitarget, Multihit Survival 31 2. 6 Single-target, Multihit Survival 31 2.Table of Contents1 General Introduction.- 1.1 Introduction.- 1.2 History of Cancer and its Treatment by Radiotherapy.- 1.3 Some Mathematical Models of Tumor Growth.- 1.4 Spatial Distribution of the Radiation Dose.- 2 Survival Curves from Statistical Models.- 2.1 Introduction.- 2.2 The Target Model.- 2.3 Single-hit-to-kill Model.- 2.4 Multitarget, Single-hit Survival.- 2.5 Multitarget, Multihit Survival.- 2.6 Single-target, Multihit Survival.- 2.7 Properties of In Vitro Survival Curves.- 3 A Molecular Model of cell Survival.- 3.1 Introduction.- 3.2 The Molecular Model.- 3.3 Interpretations of the Molecular Model.- 4 Kinetic Models of Biological Radiation Response.- 4.1 Introduction.- 4.2 Basic Postulates in the Dienes Model.- 4.3 Low LET Kinetic Models with no Recovery.- 4.4 Further Discussion of the Models.- 4.5 Low LET Kinetic Models with Recovery.- 4.6 Low LET and High LET Kinetic Model with No Recovery.- 4.7 Other Kinetic Schemes: Sparsely-ionizing Radiation.- 4.8 Kinetic Schemes with Age-specific Compartments in the Cell Cycle.- 4.9 Thermal Potentiation of Cell Killing.- 5 Cell Survival after Successive Radiation Fractions.- 5.1 Introduction.- 5.2 Some Results in Connection with Instantaneous Cell Kill and Exponential Tumor Growth.- 5.3 Instantaneous Cell Kill Followed by Logistic Growth of Normal Tissue.- 5.4 Cohen’s Cell Population Kinetics Programs.- 5.5 A Model of Radiation Therapy with Resistant and Sensitive Cell Populations.- 5.6 Dose Fractionation and General Survival Curves.- 6 Optimization Models in Solid Tumor Radiotherapy.- 6.1 Introduction.- 6.2 Optimal Radiotherapy of Tumor Cells Based on Cumulative Radiation Effect and a Multitarget, Single-hit Survival Function.- 6.3 Optimal Radiotherapy of Tumor Cells Based on Cumulative Radiation Effect and an Exponential-quadratic Survival Expression.- 6.4 Fractionation Scheme with a Four Level Population Tumor Model.- 6.5 A Dynamic Programming Solution to the Problem of the Determination of Optimal Treatment Schedules.- 6.6 Optimal Treatment Schedules in Fractionated Radiation Therapy for Fischer’s Tumor Model.- 6.7 Optimal Radiation Schedules with Cell Cycle Analysis.- 7 Numerical Solution of Multistage Optimal Control Problems.- 7.1 Introduction.- 7.2 Continuous Time Optimal Control.- 7.3 Optimization of Multistage Systems.- 7.4 Multi-dimensional Optimization by Gradient Methods.- 7.5 Gradient Method with Penalty Function.- 7.6 A Numerical Scheme for a Nonlinear Problem.- 7.7 The Method of Conjugate Gradients.- 7.8 Discrete Dynamic Programming.- 8 Some Optimization Criteria in Radiotherapy.- 8.1 Introduction.- 8.2 Therapeutic Policy, Strategy and Tactics.- 8.3 Optimization and Clinical Trials.- 8.4 Score Functions and Age Response Functions.- 8.5 Comparison of Models Used in Optimization Procedures.- 8.6 The Complication Probability Factor.- 9 The Optimization of External Beam Radiation Therapy.- 9.1 Introduction.- 9.2 Some Approaches for Treatment Plans.- 9.3 Linear Programming.- 9.4 Linear Programming and Radiation Treatment Planning.- 9.5 Optimization of External Beam Radiation Therapy Using Nonlinear Programming.- 9.6 Quantitative Study of Relative Radiation Effects and Isoeffect Patterns.- 10 Reconstructive Tomography.- 10.1 Introduction.- 10.2 Reconstruction Algorithm.- 10.3 Numerical Approximations for the Attenuation Coefficient.- 10.4 Cross-sectional Absorption Density Reconstruction for Treatment Planning.- 10.5 Towards the Optimization of Dose Reduction in Computerized Tomography.- 10.6 Other Imaging Technologies.- Appendix 1.- Appendix 2.- Appendix 3.

Read more less

Book SynopsisDie psychosoziale Rehabilitation Krebskranker ist ein Thema von standig wachsender Bedeutung. Die fachgerechte psychosoziale Nachsorge erfordert jedoch auch eine intensive systematische Rehabilitationsforschung. Deutsche und internationale Psychoonkologen und Rehabilitationsforscher stellen in diesem Buch aktuelle Entwicklungen auf diesem Gebiet vor. Das Themenspektrum umfasst Forschungsstrategien, Krankheitsbewaltigung, Lebensqualitat, soziale Unterstutzung, Bedarf an psychosozialer Hilfe sowie die Gestaltung von psychologischen Interventionen im Verlauf von Krebserkrankungen. Forschungsgruppen informieren uber verschiedene, vom Bundesministerium fur Forschung und Technologie geforderte Projekte mit den Schwerpunkten "Krankheitsverarbeitung und -bewaltigung", "Belastung von in der Onkologie tatigen Berufsgruppen" und "Versorgungsmodelle und Versorgungsstrukturen". Die Darstellung der Forschungsansatze und -strukturen, der inhaltlichen Zielrichtung der Projekte, zeigt eindrucksvoll die Entwicklungsmoglichkeiten dieses Forschungsbereiches auf. Arzten, Psychologen und Soziologen in Forschung und Praxis bietet das Buch einen aktuellen Uberblick zum Stand der psychosozialen Forschung in der Rehabilitation Krebskranker.Table of Contents1: Aktuelle Trends in der Krebsrehabilitation und Psychoonkologie.- Einige Überlegungen zu praktischen Aspekten und Problemen der Forschung zur Krebsrehabilitation.- Psychologische Aspekte der Bewältigung einer Krebserkrankung.- Lebensqualität und Krebsbehandlung.- Die Rolle des Ehepartners als emotionale Stütze des Krebspatienten.- Ätiologie und Therapie der psychologischen Nebenwirkungen von Chemotherapie bei Krebs: kritischer Überblick und Diskussion.- Schmerzen bei Krebserkrankungen — Bedeutung, Behandlung und Bewältigung.- Bedarf an psychosozialer Versorgung von Tumorpatienten. Theoretische Aspekte zum Begriff des Bedarfs und die Problematik der Bedarfsplanung.- Bedarf an psychosozialer Betreuung von Krebskranken und Anforderungen an die psychosoziale Personalfortbildung.- Wechselwirkungen zwischen Rehabilitation und Prävention: Implikationen für die künftige Forschung zur Rehabilitation bei Krebserkrankungen.- 2: Förderschwerpunkt „Rehabilitation von Krebskranken“.- 2.1 Einführung und Überblick.- 2.2 Vorhaben zur Krankheitsverarbeitung und Krankheitsbewältigung.- Elemente subjektiver Krankheitstheorien: ihre Bedeutung für die Krankheitsbewältigung, soziale Interaktion und Rehabilitation von Krebskranken.- Affektive und kognitive Verarbeitung des Krankheitsgeschehens krebskranker Patienten.- Krankheitsverarbeitung und Möglichkeiten psychosozialer Hilfen bei verschiedenen Gruppen erwachsener Krebskranker. Eine vergleichende Querschnitt- und Verlaufsuntersuchung.- Belastungsverarbeitung bei Krebskranken in der Rezidiv- und Metastasierungsphase, ihre Bedeutung für Therapie und Nachsorge. Eine methodenintegrative Längsschnittstudie.- Rehabilitation von Patienten mit Non-Hodgkin-Lymphomen: Kontrollierbarkeit, Bewältigungsverhalten und Rehabilitationsergebnis.- 2.3 Vorhaben zu Belastungen bei in der Onkologie tätigen Berufsgruppen.- Psychosoziale Belastungen bei Ärzten/Ärztinnen und Krankenpflegekräften im Krankenhaus.- Belastungen und Belastungsverarbeitung bei onkologisch tätigen Ärzten und Pflegekräften.- 2.4 Vorhaben zu Versorgungsmodellen und Versorgungsstrukturen.- Evaluation eines psychosozialen Versorgungsmodells im Rahmen der stationären internistischen Akutversorgung onkologischer Patienten.- Verknüpfung von ambulanter und stationärer Behandlung durch Förderung der Beziehung zwischen Krebskranken und sozialem Umfeld im Rahmen einer onkologischen Tagesklinik.- Der Krebskranke in seiner Familie: wechselseitige Belastung und Unterstützung. Psychosoziale Bedingungen und Auswirkungen ambulanter Tumortherapie.- Evaluation von Rehabilitationsmaßnahmen bei Krebspatienten. Zentrale Fragen und erste Ergebnisse eines Forschungsprojekts.- Inanspruchnahme von Nachbetreuungsmaßnahmen für Brustkrebspatientinnen.- Kosten-Wirksamkeits-Analyse der Rehabilitation Krebskranker. Einige Anmerkungen zur Effizienzmessung.- 2.5 Vorhaben zur Erprobung von psychosozialèn Versorgungskonzepten und Interventionsstrategien.- 2.6 Rehabilitation von Krebskranken — Bilanz eines Förderschwerpunkts nach drei Jahren.

Read more less

Book SynopsisDiagnose-Schock: KrebsDiagnose Krebs: Über 500.000 Menschen in Deutschland, Österreich und der Schweiz erhalten jährlich die Diagnose Krebs. Die medizinischen Fragestellungen haben dann Priorität, oft wird aber die psychologische Betreuung der Patienten auch im Verlauf der Behandlung zu wenig berücksichtigt. Studien zeigen zudem, dass die Partner Krebsbetroffener häufig noch stärker belastet sind als die Patienten. Hilfe für die Seele Dieses Buch bietet praktische Unterstützung für beide Seiten: Patienten und ihre Partner, Freunde, Begleiter. Ziele des Buches: - Sorgen und Hilflosigkeit vermindern- Ihre Lebensqualität verbessern - Selbsthilfe und Selbststeuerung anregen- Sie unterstützen, mit der Erkrankung umzugehen und für sich selbst zu sorgen- Sie unterstützen, Ihren eigenen Weg zu finden- Ihnen in schwierigen Situationen Möglichkeiten aufzeigen- Sie unterstützen, wichtige Dinge nicht zu verpassen.Als klinisch tätige Psychoonkologen zeigen die Autoren vielfach erprobte Hilfestellungen auf. Leserinnen und Leser erhalten kurze, gut lesbare Erklärungen und Anleitungen, die die Ressource Menschlichkeit nutzen. Geschrieben ist das Buch für Betroffene und Angehörige sowie für medizinische und psychosoziale Fachleute in Klinik, Praxis und Reha, die mit Krebsbetroffenen arbeiten. Der praktische Ratgeber für Betroffene und Angehörige: In der Krise lesbar und bezogen auf den ganzen MenschenTrade ReviewAus den Rezensionen: “Das handliche Buch bildet ein klar strukturiertes Kompendium psychologischer und psychoonkologischer (Er-)Kenntnisse ... Ein gut lesbarer Ratgeber für Betroffene und Angehörige. Für medizinisches und psychosoziales Fachpersonal eine hilfreiche Darstellung möglicher Auswirkungen der Diagnose Krebs.“ (Manfred Gaspar, in: Zeitschrift für Palliativmedizin, März 2014, Jg. 15, Heft 2)Table of Contents1. Klärungen als Hilfe.- 2. Hilfen zum Umgang mit schwierigen Situationen.- 3. Hilfen zum Umgang mit schwierigen Gefühlen.- 4. Praktische Hilfen zur Lebensgestaltung.- 5. Hilfen zum Umgang mit unheilbarer Krankheit.- 6. Erfahrungsberichte.- 7. Empfohlene Literatur und Internet-Links.- 8. Psychoonkologische Beratung und Therapie.

Read more less

Book SynopsisAn in-depth introduction to radiotherapy physics emphasizing the clinical aspects of the field. This second edition gradually and sequentially develops each of its topics in clear and concise language. It includes important mathematical analyses, yet is written so that these sections can be skipped, if desired, without compromising understanding. The book consists of seven parts covering basic physics (Parts I-II), equipment for radiotherapy (Part III), radiation dosimetry (Parts IV-V), radiation treatment planning (Part VI), and radiation safety and shielding (Part VII). An invaluable text for radiation oncologists, radiation therapists, and clinical physicists.Table of Contents1 Scope of Clinical Radiotherapy Physics.- 2 Atoms, Molecules, and Matter.- 3 Propagation of Energy by Electromagnetic Waves.- 4 Nuclear Transitions and Radioactive Decay.- 5 Radioactive Decay Calculations.- 6 Collision and Radiation Loss in Charged-Particle Interactions.- 7 Photon Interactions.- 8 Conventional X-Ray Machines.- 9 Equipment for Radioisotope Teletherapy.- 10 Particle Accelerators.- 11 Quantification of Radiation Field: Radiation Units and Measurements.- 12 Instruments for Radiation Detection.- 13 Basic Ratios and Factors for the Dosimetry of External Beam.- 14 Beam Dosimetry: Additional Corrections — Special Situations.- 15 Treatment Dose Distribution Planning: Photon Beams.- 16 Physical Aspects of Electron Beam Therapy.- 17 Physics of the Use of Small Sealed Sources in Brachytherapy.- 18 Radiation Safety Standards.- 19 Radiation Safety in External-Beam Therapy.- 20 Radiation Safety in Brachytherapy.- Appendix A and B.

Read more less

Book SynopsisÖsophaguskarzinom.- Magenfrühkarzinom.- Dünndarmtumoren.- Dickdarmkarzinom.- Rektumkarzinom.- Primäre und sekundäre Malignome der Leber.- Pankreaskarzinom.- Palliative Eingriffe beim Verschlußikterus.- Papilläres Schilddrüsenkarzinom: Chirurgisch-therapeutische und prognostische Gesichtspunkte.- Wilms-Tumor Besonderheiten und kinderchirurgische Aspekte.- Neuroblastom.- Prophylaktische und therapeutische Lymphadenektomie beim malignen Melanom der Haut.- Weichteilsarkome.- Maligne Knochentumoren.- Diagnostische und chirurgische Aspekte der Karotisglomustumoren.- Herztumoren.- Bronchialkarzinom.- Nil nocere in der Primärtherapie des Mammakarzinoms.- Plastische Eingriffe in der onkologischen Mammachirurgie.- Prostatakarzinom.- Nierenkarzinom.Table of ContentsÖsophaguskarzinom.- Magenfrühkarzinom.- Dünndarmtumoren.- Dickdarmkarzinom.- Rektumkarzinom.- Primäre und sekundäre Malignome der Leber.- Pankreaskarzinom.- Palliative Eingriffe beim Verschlußikterus.- Papilläres Schilddrüsenkarzinom: Chirurgisch-therapeutische und prognostische Gesichtspunkte.- Wilms-Tumor — Besonderheiten und kinderchirurgische Aspekte.- Neuroblastom.- Prophylaktische und therapeutische Lymphadenektomie beim malignen Melanom der Haut.- Weichteilsarkome.- Maligne Knochentumoren.- Diagnostische und chirurgische Aspekte der Karotisglomustumoren.- Herztumoren.- Bronchialkarzinom.- Nil nocere in der Primärtherapie des Mammakarzinoms.- Plastische Eingriffe in der onkologischen Mammachirurgie.- Prostatakarzinom.- Nierenkarzinom.

Read more less

Book SynopsisDas Buch informiert über die operative und konservative Therapie sämtlicher Stadien des Harnblasenkrebses. Entsprechend der großen Bedeutung der histologischen Einschätzung der Tumorausbreitung und Bösartigkeit wird die pathologische Anatomie des Harnblasenkarzinoms ausführlich dargestellt. Bei den operativen Verfahren steht die transurethrale Tumorresektion im Vordergrund. Eine Verbesserung der operativen Behandlung, insbesondere der fortgeschrittenen Stadien des Harnblasenkrebses, bieten die Methoden der integrierten Therapie. Hierzu gehören Chemo- und Strahlentherapie, aber auch die neuesten Verfahren wie die lokale Hyperthermie. Insbesondere die komplizierte integrierte Therapie nimmt in dem Buch breiten Raum ein. Bei den Einzeldarstellungen der verschiedenen tragenden Säulen der integrierten Therapie (Operation, Chemotherapie, Strahlenbehandlung und Hyperthermie) wird übergreifend versucht, das Ineinanderspiel der verschiedenen Therapieformen deutlich zu machen. Die Laserbehandlung, die photodynamische Therapie sowie der Stand der Immuntherapie werden ihrer Bedeutung entsprechend abgehandelt. Die praxisnahe, übersichtliche Darstellung des Themas macht das Buch für Urologen und andere, mit dem Problem befaßten Ärzte in Klinik und Praxis zu einem aktuellen Nachschlagewerk und Ratgeber.Table of ContentsEinführung.- Pathologische Anatomie des Harnblasenkarzinoms.- Operative Therapie des Harnblasenkarzinoms (Mit 8 Abbildungen).- Strahlentherapie des Harnblasenkarzinoms.- Systemische Chemotherapie beim metastasierten Harnblasenkarzinom.- Lokale Therapiekonzepte beim Harnblasenkarzinom a) Intravesikale Zytostatikainstillation b) Integrierte Behandlung durch intraarterielle Zytostatikainfusion und transurethrale Hochfrequenzhyperthermie (Mit 12 Abbildungen).- Transurethrale lokale Hochfrequenzhyperthermie des Harnblasenkarzinoms (Mit 9 Abbildungen).- Laserbehandlung von Urogenital-Tumoren (Mit 6 Abbildungen).- Integrale photodynamische Therapie des multifokalen Blasenkarzinoms nach Photosensibilisierung mit Hämatoporphyrinderivat (HpD) (Mit 6 Abbildungen).- Immuntherapie beim Harnblasenkarzinom (Mit 4 Abbildungen).- Glossar der onkologischen Therapie des Harnblasenkarzinoms.

Read more less

Book SynopsisThe European Organization for Research into Cancer Treatment (OERTC), founded in 1962 initially under the name Groupe Europeen de Chimiotherapie Anti­ cancereuse (GECA), is an extramural European Institute for collecting, co-ordinating and encouraging the work of scientists researching into cancer treatment at 16 European institutes: 3 in W. Germany, 2 in Italy, 2 in Belgium, 3 in the Netherlands, 2 in the United Kingdom, 1 in Switzerland and 3 in France. The first President of OERTC was Professor GEORGES MATHE, now succeeded by Professor SILVIO GARATTINI of Milan. The organization has a Board of 20 Directors, responsible for co-ordinating the entire range of activities and guiding research and experimental studies on animals, also the first human trials of new therapeutic agents which have been fully tested on animals. The Co-operating Groups carry out com­ plementary testing involving large numbers of patients. Thus, OER TC is not a "learned society" but an agency for co-ordinating work. OER TC's annual plenary meeting for 1968 was held in Paris on 22nd and 23rd March. It was given over to an intensive study of the scientific basis of chemotherapy in the treatment of cancer in man. These two working sessions brought together members of all groups, both directing and co-operating. The first day was in effect a teaching seminar, open to all practitioners wishing to use chemotherapy in cancer, and explaining the scientific basis of such treatment. This seminar constitutes the present monograph.Table of ContentsAnti-Cancer Agents. Their Detection by Screening Tests and their Mechanism of Action.- Extracellular Factors Affecting the Response of Tumours to Chemotherapeutic Agents.- Intracellular Factors Influencing the Response of Tumours to Chemotherapeutic Agents.- Chemotherapy and Immune Reactions.- Dose Schedules and Modes of Administration of Chemotherapeutic Agents in Man.- The Methodology of Controlled Clinical Trials.- Biological Basis of Hormonal Therapy of Cancer.- Operational Research in Cancer Chemotherapy. Chemotherapy in the Strategy of Cancer Treatment.

Read more less

Book Synopsis(1952), HoRNING (1956), DoNTENWILL und EDER (1959)]. Wir sahen dabei fast immer basophile Adenome mit z. T. hochgradiger Zellpolymorphie und typischen Crooke-Zellen rpit Vacuolen (Abb. 3a u. b). Die Adenome fiihrten hiiufig zu De- formierungen der Schiidelbasis. Bei diesen Adenomen konnten keine Veriinderun- gen an den endokrinen Driisen oder endokrin gesteuerten Organen nachgewiesen werden, die auf eine Mehrsekretion der vergr6Berten Hypophyse hindeuten. 1. Spezielle Hypophysenadenome Wahrend bei den bisher angefiihrten Adenomen oder Hyperplasien keine be- stimmte Differenzierung nach ihrer Sekretion bzw. Leistung vorgenommen werden konnte, wurden in den letzten Jahren besonders von FURTH (1955, 1957, 1958), FURTH und CLIFTON (1957), CLIFTON (1959) eine Reihe von verschiedenartigen Hypophysenadenomen beschrieben [Obersicht iiber diese Hypophysenade- nome, ihre Ursachen, ihre hormonelle Leistung bzw. Struktur zeigt ein Schema (Tab. 1) aus der Monographie von KwA HoNG GroG (1961)], die als mammatrope, adrenocorticotrope, thyreotrope, somatothyreotrope und amphophile Adenome bezeichnet wurden. Die Differenzierung dieser Adenome bezieht sich z. T. auf ihre spezifische Leistung, z. T. auf ihre typische Zellstruktur. RussFIELD, FRIEDLER Tabelle I. Schematische Einteilung der Hypophysentumoren bei Maus und Ratte Proliferierender Zelltyp anznnehmende Art der Experimentelle Bedingungen tatsiichlich Hormonbildung Hypophysenstimuliernng 1eoretisch erwartet beobachtet tsophiler {J-Z entgranulierter TSH (,thyro- Chirurgische Schilddriisen- Unterbrechung des basophiler trophin" usw. ) entfernung; ,Radiothy- W echselmechanismus {J-Z.Table of ContentsTumours arising from vertical transmission.- Erzeugung von Tumoren durch endogenhormonelle Faktoren.- Zusammenfassung.- Namenverzeichnis.

Read more less

Book SynopsisKrebserkrankte, ihre Angehörigen sowie Freunde und Behandler erhalten in diesem Ratgeber einfache und verständliche Informationen zu wichtigen Aspekten von Krebserkrankungen. Die Themenauswahl basiert auf der Aachener Veranstaltungsreihe "leben mit krebs", welche ganz nah an den Bedürfnissen der Besucher ausgerichtet ist und geht weit über die rein medizinische Versorgung hinaus. Dieses Buch unterstützt bei der Bewältigung einer Krebserkrankung und ihrer Folgen, vermittelt Informationen wie beispielsweise zu Angstbewältigung, Ernährung und Bewegung, Sexualität und Patientenverfügung auf verständliche Art und ermutigt zur eigenen Informiertheit. Praktische Tipps und Hilfestellungen für häufig nicht offen angesprochene Situationen des "Alltags" erleichtern Austausch und Gespräche zwischen allen Beteiligten. Die Autoren greifen auf ihren reichen Erfahrungsschatz aus der Behandlung von Krebspatienten und aus der Veranstaltungsreihe "leben mit krebs" zurück.Trade Review“... Mir war es ein Vergnügen, diese Ratgeber-Broschüre zu lesen. Während der Lektüre stellte sich wiederholt der Wunsch ein, die Broschüre neben den Patienten und Patientinnen ebenfalls allen Pesonen [sic], die professionell in der Betreuung von Menschen mit Krebserkrankungen tätig sind, ans Herz zu legen und nicht zuletzt auch in den Unterricht von Studierenden zu integrieren.” (M. Von Lilienfeld-Toal, in: best practice onkologie, Heft 4, April 2022)Table of ContentsÜber- „leben mit krebs.- Hoffnung auf ein gutes Leben während und nach einer Krebserkrankung.- Hoffnung auf gesundes Leben.- Hoffnung auf ein abgesichertes Leben.- Hoffnung für spezielle Gruppen.- Hoffnung auf Alltag.

Read more less

Book SynopsisDiagnose Krebs – füreinander da sein! Dieser Ratgeber richtet sich an Paare, bei denen der Mann an Krebs erkrankt ist. Er unterstützt die Partnerin bzw. den Partner des Erkrankten und bietet Hilfe bei der Bewältigung paarbezogener Belastungen und Herausforderungen. Die Diagnose Krebs stellt das ganze Leben auf den Kopf. Jeder Lebensbereich ist betroffen, unzählige Fragen kommen auf, Perspektiven verändern sich: Werde ich wieder gesund? Was wird aus meiner Beziehung? Warum musste ich krank werden, was habe ich falsch gemacht? Auch die Angehörigen sehen sich im Spannungsfeld von eigenen Belastungen und Sorge um ihren Partner vielfach mit Problemen konfrontiert. Die erfahrenen Autoren gehen einfühlsam und sachkundig auf die konkreten Herausforderungen im Lebensalltag von Krebspatienten ein. Viele Beispiele und Übungen helfen den Lesern, die eigene Situation besser zu verstehen und einzuordnen. Table of Contents

Read more less

Book SynopsisGynaecologic oncology is one of the most important subjects in gynaecology and a very challenging field. The management of patients with gynaecological cancers is complex, as the impact of the outcome of such cancers can be critical. This handbook covers the basics of carcinogenesis and the advances in the prevention and management of all gynaecologic cancers, including breast cancer. Gynaecologic oncology has always been perceived as the most difficult subject in obstetrics and gynaecology, but this handbook proves it otherwise. The text is presented in a systematic and easy-to-understand manner and is supplemented by plenty of images and illustrations and up-to-date references from established sources. The book also introduces readers to the new FIGO 2009 staging system and will be a very useful reference for researchers and clinicians.Trade Review"This comprehensive handbook covers the essentials of gynaecological oncology. The text includes all pelvic tumours as well as breast cancer, cancer in pregnancy, and fertility-sparing possibilities. It outlines well the complications of treatment with the basics of radiotherapy and chemotherapy. This is a good book for the aspiring junior doctor to have as a guide for current clinical practice and to review before ‘that exam’. A well-worth buy!"Prof. John H. Shepherd, Royal Marsden Hospital, UK"This book presents a comprehensive collection of information on gynaecologic oncology in a systematic and easy-to-understand manner. I am convinced that students, young gynaecologists, and gynaecologic oncologists will enjoy reading this informative text."Dr. Shingo Fujii, Kitano Hospital, JapanTable of ContentsWorld Cancer Statistics and Burden of Gynae Cancer. Genes and Carcinogenesis. Cancer of Vulva. Cancer of Vagina. Screening for Cervical Cancer. Human Papillomavirus and HPV Vaccine. Management of Pre-invasive Disease of Cervix. Cancer of Cervix. Cancer of Endometrium. Uterine Sarcoma. Cancer of Fallopian tube. Cancer of Ovary (Epithelial). Ovarian Germ Cell Tumours. Ovarian Sex Cord Stromal Tumours. Gestational Trophoblastic Disease. Breast Cancer for Gynaecologic Oncologist. Gynaecologic Cancer in Pregnancy. Tumour Markers in Gynaecologic Oncology. Diagnostic Imaging in Gynaecologic Oncology. Peri-operative Care for Gynaecologic Cancer Patients. Basic Anatomy and Principles of Surgery in Gynae Oncology. Basic Principles of Radiotherapy. Basic Principles of Chemotherapy. Modulating Agents,Response Modifier and Targeted Therapy. Immunotherapy and Hormonal Therapy. Management of Long-term Side Effects of Gynae Cancer Treatment. Nutritional Support For Gynaecologic Cancer Patients. Basic Surgical Procedures in Gynaecologic Oncology. Laparoscopic and Robotic Surgery in Gynaecologic Cancers. Index.

Read more less

Book SynopsisNanomaterials have the potential to shift the paradigm for the diagnosis and treatment of many diseases, especially neoplasms, because of the intriguing behaviors associated with their unique size-/shape-influenced chemical, physical, and physiological features. Currently, there is a huge imbalance between the several nanoplatforms reported in the literature and the few ones approved for clinical applications. This disequilibrium affects, in particular, plasmonic nanomaterials, which present no approved platforms and few candidates in clinical trials. This trend can be reversed by promoting collaborations among scientists from different fields as well as by improving the multidisciplinary background of researchers interested in this area. This book is a collection of must-read peer-reviewed papers focusing on (i) the main behaviors of nanomaterials for nanomedicine, (ii) key features nanomaterials need for successful translation to the clinical setting, and (iii) market analysis of nanomaterials at the bedside or on the way. The main aim of this book is to offer a comprehensive point of view to students and researchers in order to promote the translation of new technologies to patients. It is a unique reference for advanced undergraduate- and graduate-level students of nanotechnology and researchers in materials science, nanotechnology, chemistry, biology, and medicine, especially those with an interest in cancer theranostics.Table of ContentsDetecting and Destroying Cancer Cells in More Than One Way with Noble Metals and Different Confinement Properties on the Nanoscale. Engineered Nanoparticles for Drug Delivery in Cancer Therapy. Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles. Gold Nanomaterials at Work in Biomedicine. The Nanomedicines Alliance: An Industry Perspective on Nanomedicines. Nanomedicine(s) under the Microscope. Imaging Nano–Bio Interactions in the Kidney: Toward a Better Understanding of Nanoparticle Clearance. Nanomaterials for Theranostics: Recent Advances and Future Challenges. Metabolism of Nanomaterials in vivo: Blood Circulation and Organ Clearance.

Read more less

Book SynopsisUntil the early 1960s, cancer treatment consisted of surgery and radiation therapy. Most practitioners then viewed the treatment of terminally ill cancer patients with heroic courses of chemotherapy as highly questionable. This title explores how practitioners established a style of practice, at the center of which lies the clinical cancer trial.Trade Review"This remarkable book charts the emergence of a clinical field - medical oncology - for which experimental protocols have become routinized as a form of normal practice. Cancer on Trial will make a lasting contribution to the sociology of scientific knowledge, the history of clinical practice, and the understanding of the networked basis of biomedical research." (Jeremy A. Greene, Harvard University)"

Read more less

Book SynopsisDid America try to steal Soviet cancer secrets? And how could a cancer cure turn into a biological atom bomb? This tale of scientific discovery and politics investigates the ideological wrangling and conflicts within the Cold War search for a cure for cancer.Trade Review"A fascinating and seductively accessible account of medical science in Stalin's Russia, of the quest for a cure for cancer in the context of Cold War ideology, bureaucratic infighting, and disciplinary rivalries." - Charles Rosenberg, Harvard University

Read more less

Book SynopsisIn the 1960s, University of Cincinnati radiologist Eugene Saenger infamously conducted human experiments on patients with advanced cancer to examine how total body radiation could treat the disease. Using the Saenger case as a means to reconsider cold war medical trials, this book examines the tensions at the heart of clinical studies of the time.Trade Review"What is truly original about Contested Medicine is that, by using the science studies approach applied to a specific historical case, Kutcher shows not only how ethics were constitutive of the shape of experimental work on cancer at its inception but how both of these things were mutually changed over time." - Christopher Lawrence, Wellcome Trust Centre for the History of Medicine, University College London"

Read more less

Book Synopsis

Read more less

Book SynopsisGeneral Information on Cancer Staging and End-Results Reporting.- Purposes and Principles of Cancer Staging.- Cancer Survival Analysis.- Head and Neck.- Lip and Oral Cavity.- Pharynx.- Larynx.- Nasal Cavity and Paranasal Sinuses.- Major Salivary Glands.- Thyroid.- Mucosal Melanoma of the Head and Neck.- Digestive System.- Esophagus and Esophagogastric Junction.- Stomach.- Small Intestine.- Colon and Rectum.- Anus.- Gastrointestinal Stromal Tumor.- Neuroendocrine Tumors.- Liver.- Intrahepatic Bile Ducts.- Gallbladder.- Perihilar Bile Ducts.- Distal Bile Duct.- Ampulla of Vater.- Exocrine and Endocrine Pancreas.- Thorax.- Lung.- Pleural Mesothelioma.- Musculoskeletal Sites.- Bone.- Soft Tissue Sarcoma.- Skin.- Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas.- Merkel Cell Carcinoma.- Melanoma of the Skin.- Breast.- Breast.- Gynecologic Sites.- Vulva.- Vagina.- Cervix Uteri.- Corpus Uteri.- Ovary and Primary Peritoneal Carcinoma.- Fallopian Tube.- Gestational Trophoblastic Tumors.- Genitourinary Sites.- Penis.- Prostate.- Testis.- Kidney.- Renal Pelvis and Ureter.- Urinary Bladder.- Urethra.- Adrenal.- Ophthalmic Sites.- Carcinoma of the Eyelid.- Carcinoma of the Conjunctiva.- Malignant Melanoma of the Conjunctiva.- Malignant Melanoma of the Uvea.- Retinoblastoma.- Carcinoma of the Lacrimal Gland.- Sarcoma of the Orbit.- Ocular Adnexal Lymphoma.- Central Nervous System.- Brain and Spinal Cord.- Lymphoid Neoplasms.- Lymphoid Neoplasms.Trade ReviewFrom the reviews of the seventh edition:“Provide a new organ-specific classification that oncologists and other professionals who manage patients with cancer need in order to accurately classify tumours for staging. … a ‘Bible’ for oncologists, pathologists and surgeons, being also useful for all health officers, including general physicians and students, who want to remain updated in oncology. … this is a book that has to be present in all diagnostic imaging departments, as a major support to produce information adequate to the new oncology algorithms.”­­­ (Vincenzo Cuccurullo and Luigi Mansi, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, 2011)Table of ContentsGeneral Information on Cancer Staging and End-Results Reporting.- Purposes and Principles of Cancer Staging.- Cancer Survival Analysis.- Head and Neck.- Lip and Oral Cavity.- Pharynx.- Larynx.- Nasal Cavity and Paranasal Sinuses.- Major Salivary Glands.- Thyroid.- Mucosal Melanoma of the Head and Neck.- Digestive System.- Esophagus and Esophagogastric Junction.- Stomach.- Small Intestine.- Colon and Rectum.- Anus.- Gastrointestinal Stromal Tumor.- Neuroendocrine Tumors.- Liver.- Intrahepatic Bile Ducts.- Gallbladder.- Perihilar Bile Ducts.- Distal Bile Duct.- Ampulla of Vater.- Exocrine and Endocrine Pancreas.- Thorax.- Lung.- Pleural Mesothelioma.- Musculoskeletal Sites.- Bone.- Soft Tissue Sarcoma.- Skin.- Cutaneous Squamous Cell Carcinoma and Other Cutaneous Carcinomas.- Merkel Cell Carcinoma.- Melanoma of the Skin.- Breast.- Breast.- Gynecologic Sites.- Vulva.- Vagina.- Cervix Uteri.- Corpus Uteri.- Ovary and Primary Peritoneal Carcinoma.- Fallopian Tube.- Gestational Trophoblastic Tumors.- Genitourinary Sites.- Penis.- Prostate.- Testis.- Kidney.- Renal Pelvis and Ureter.- Urinary Bladder.- Urethra.- Adrenal.- Ophthalmic Sites.- Carcinoma of the Eyelid.- Carcinoma of the Conjunctiva.- Malignant Melanoma of the Conjunctiva.- Malignant Melanoma of the Uvea.- Retinoblastoma.- Carcinoma of the Lacrimal Gland.- Sarcoma of the Orbit.- Ocular Adnexal Lymphoma.- Central Nervous System.- Brain and Spinal Cord.- Lymphoid Neoplasms.- Lymphoid Neoplasms.

Read more less

Book SynopsisBest-selling author Pia de Jong’s vivid memoir about her daughter’s battle with leukaemia and the startling decision that led to her recovery.Trade Review"... her prose is vibrant and precise..." -- Times Literary Supplement

Read more less